UF Researchers Find New Sugar Substitutes in Citrus That Could Change Food and Beverage Industry
Finding natural, non-caloric sugar substitutes is desirable but challenging. However, researchers at the University of Florida Institute of Food and Agricultural Sciences have made a breakthrough — discovering new, natural sweeteners in citrus for the first time.
Food Advertised as ‘Scallops’ in Some Instances Are Totally Different Fish, Inside Edition Investigation Finds
an Inside Edition investigative report, with the help of UF startup and UF Innovate | Accelerate graduate Applied Food Technologies, found samples of seafood advertised to be “scallops” at restaurants across the United States to be anything but.
How Members of the UF Community Represent the Core Values
University of Florida Core Values Week strives to make the university community a premier university in the state, nation and world to look to for leadership.
UF Health Researcher Aims To Create AI Algorithm To Help Map Human Body’s Cells
Recently hired UF College of Medicine faculty member Pinaki Sarder, Ph.D., is leading a project where researchers at UF Health are developing an artificial intelligence algorithm to be used by scientists around the nation who are mapping out the entire human body at the single-cell level.
UF Researchers Use AI To Predict New Coronavirus Variants
A new research grant led by University of Florida professors and is attempting to see if AI can help predict the next wave of coronavirus.
Concept Companies and Lacerta Therapeutics Form a Strategic Partnership Around Facilities Expansion and Financing
Concept Companies, a national commercial real estate developer with a specialty across multiple asset classes including science and technology, and Lacerta Therapeutics, Inc., a leader in the AAV gene therapy space, today announced a strategic collaboration providing Lacerta with access to financing to support expansion of operations and new facilities. The financing is being provided via Agility Venture Capital, the funding arm of Concept Companies.
UF Scripps Study: Opioid Drug Tolerance Develops From Interplay of Key Gene and Cholesterol
UF Scripps Biomedical Research scientists have discovered a key gene that is shedding light on how people develop tolerance to pain-relievers over time, a problem that raises risk of addiction and overdose.
Lacerta and Prevail, a Wholly Owned Subsidiary of Lilly, Sign Agreement To Develop Novel AAV Capsids for CNS Disorders
Lacerta Therapeutics, a leader in the development of adeno-associated virus (AAV) technologies for the treatment of central nervous system (CNS) diseases, announced a new AAV capsid licensing and research collaboration agreement with Prevail Therapeutics, a wholly owned subsidiary of Eli Lilly and Company. The collaboration will focus on the discovery and development of novel AAV capsids for CNS diseases.
UF Health research sheds new light on nicotine and morning brew
In a cell-based study, UF researchers identified two compounds in coffee that directly affect certain high-sensitivity nicotine receptors in the brain. In smokers, these brain receptors can be hypersensitive after a night of nicotine withdrawal.
UF Accelerate Residents Announced As Finalists for the 12th Annual GrowFL Florida Companies To Watch
UF Accelerate | Sid Martin Biotech resident Neobiosis, and UF Accelerate | The Hub resident Quottly, have been selected as finalists for this year’s annual GrowFL Florida companies to watch.